Company intelligence / Profile preview

OptoSeeker Biotech

Ownership: Private
Development stage: Phase 1

Overview

OptoSeeker Biotech is a biotechnology company based in Shanghai, China. The CEO and Co-founder is Hainan Xie, who has previous experience at Fresenius. No further public details about the company's pipeline, technology focus, or clinical results are currently available[1].

Industry: Biotech

Drug pipeline

1 asset

AK0707

Phase 1

Indications: Idiopathic pulmonary fibrosis, Systemic sclerosis, Neuropathic pain, Liver fibrosis, Cancer

Beyond the preview

Go deeper on OptoSeeker Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptoSeeker Biotech.

Explore the full profile